FLPIM
IBB icon

F.L. Putnam Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

F.L. Putnam Investment Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$443K Buy
2,441
+342
+16% +$58.8K 0.01% 486
2026
Q1 		$354K Sell
2,099
-80
-4% -$13.7K 0.01% 481
2025
Q4 		$368K Hold
2,179
– – 0.01% 478
2025
Q3 		$315K Buy
2,179
+105
+5% +$14.3K ﹤0.01% 497
2025
Q2 		$262K Sell
2,074
-49
-2% -$6.01K ﹤0.01% 513
2025
Q1 		$272K Buy
2,123
+397
+23% +$53.8K 0.01% 506
2024
Q4 		$228K Buy
1,726
+9
+0.5% +$1.26K ﹤0.01% 532
2024
Q3 		$250K Sell
1,717
-9
-0.5% -$1.3K ﹤0.01% 523
2024
Q2 		$237K Buy
1,726
+224
+15% +$29.9K ﹤0.01% 515
2024
Q1 		$206K Hold
1,502
– – ﹤0.01% 466
2023
Q4 		$204K Buy
+1,502
New +$183K ﹤0.01% 459
2023
Q1 		– Sell
-1,755
Closed -$230K – 430
2022
Q4 		$230K Sell
1,755
-30
-2% -$3.88K 0.01% 378
2022
Q3 		$209K Sell
1,785
-298
-14% -$37K 0.01% 379
2022
Q2 		$245K Buy
2,083
+19
+0.9% +$2.25K 0.01% 362
2022
Q1 		$269K Sell
2,064
-135
-6% -$17.6K 0.01% 358
2021
Q4 		$336K Sell
2,199
-92
-4% -$14.2K 0.01% 325
2021
Q3 		$370K Sell
2,291
-69
-3% -$11.6K 0.01% 310
2021
Q2 		$386K Sell
2,360
-29
-1% -$4.47K 0.01% 309
2021
Q1 		$360K Sell
2,389
-360
-13% -$57.2K 0.02% 282
2020
Q4 		$416K Sell
2,749
-63
-2% -$9K 0.02% 245
2020
Q3 		$381K Sell
2,812
-727
-21% -$98.6K 0.02% 224
2020
Q2 		$484K Buy
3,539
+43
+1% +$5.48K 0.03% 208
2020
Q1 		$377K Sell
3,496
-219
-6% -$25.2K 0.03% 218
2019
Q4 		$448K Sell
3,715
-95
-2% -$10.6K 0.03% 221
2019
Q3 		$379K Buy
3,810
+2,127
+126% +$223K 0.03% 221
2019
Q2 		$184K Sell
1,683
-236
-12% -$25.1K 0.01% 225
2019
Q1 		$215K Buy
+1,919
New +$210K 0.02% 212

Other funds holding IBB

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return

F.L. Putnam Investment Management's IBB Position: Q2 2026 in Review

F.L. Putnam Investment Management increased its iShares Biotechnology ETF (IBB) stake by 16% in Q2 2026, buying an estimated $58.8K and bringing the position to 2,441 shares worth $443K. The position accounts for 0.01% of the portfolio, ranked #486.

F.L. Putnam Investment Management first reported a position in IBB in Q1 2019 and has held it in 27 quarters since. The position peaked at $484K in Q2 2020. 653 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • F.L. Putnam Investment Management held 2,441 shares of iShares Biotechnology ETF worth $443K as of Q2 2026.
  • F.L. Putnam Investment Management bought 342 iShares Biotechnology ETF shares in Q2 2026, an estimated $58.8K.
  • iShares Biotechnology ETF made up 0.01% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #486 holding.
  • F.L. Putnam Investment Management first reported a position in iShares Biotechnology ETF in Q1 2019 and has held it in 27 quarters since.
  • F.L. Putnam Investment Management's iShares Biotechnology ETF position peaked at $484K in Q2 2020.
  • 653 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.